Cargando…
Subclinical Hypothyroidism in TAFRO Syndrome
OBJECTIVE: TAFRO syndrome is rare, and its underlying mechanisms currently remain unknown. Furthermore, standard therapeutic strategies have yet to be established. One of the hallmarks of TAFRO is pathological hypercytokinemia, which involves vascular endothelial growth factor (VEGF). A correlation...
Autores principales: | Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794168/ https://www.ncbi.nlm.nih.gov/pubmed/31178506 http://dx.doi.org/10.2169/internalmedicine.2717-19 |
Ejemplares similares
-
Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
por: Oka, Satoko, et al.
Publicado: (2018) -
Successful Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Neuro-Sweet Disease in Myelodysplastic Syndrome
por: Oka, Satoko, et al.
Publicado: (2017) -
The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome
por: Oka, Satoko, et al.
Publicado: (2020) -
Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation
por: Oka, Satoko, et al.
Publicado: (2017) -
Effective maintenance treatment with lenalidomide for a patient with aggressive adult T cell leukemia after chemotherapy
por: Oka, Satoko, et al.
Publicado: (2019)